Genetic tests could pave way to ‘personalised’ asthma drugs

| | January 8, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Routine and inexpensive genetic testing could save a significant number of children from being given drugs that fail to help their asthma and may even make it worse, scientists say.

It is accepted that specific medicines work better on some people than on others. Drug companies are exploring the possibilities for personalised medicines: drugs targeted to an individual’s genetic makeup, which will therefore be much more effective.

But the reverse also holds true: that some drugs are likely to be ineffective and cause more side-effects in some people than in others.

View the original article here: Genetic tests could pave way to ‘personalised’ asthma drugs

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend